{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:27:59Z","timestamp":1789003679522,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":275,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20IPA35310955"],"award-info":[{"award-number":["20IPA35310955"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20IPA35310955"],"award-info":[{"award-number":["20IPA35310955"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with heart failure (HF), independent of shared risk factors. Our aim was to describe the incidence of HF in patients with biopsy-proven MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We followed patients with biopsy-proven MASLD from the prospective Duke NAFLD Biorepository and Clinical Database from liver biopsy (2007\u20132013) until death or 5 January 2023. Clinical and echocardiographic data were abstracted via manual chart review. Incident HF was defined as one of the following: (1) hospitalization for HF, (2) medical record diagnosis of HF, (3) \u22651 sign\/symptom of HF and elevated natriuretic peptide, or (4) diastolic dysfunction on transthoracic echocardiography with \u22651 sign\/symptom of HF. Univariable and multivariable logistic regression models were evaluated. Overall, 570 patients with biopsy-proven MASLD were included. The mean age was 49.5\u2009years, 42.5% were male and 87.0% were non-Hispanic White. Ten patients (1.8%) had baseline HF, leaving 560 patients to assess for incident HF. Over a median follow up of 4009\u2009days (11.0\u2009years) (interquartile range 2270\u20134672\u2009days), 100 (17.9%) patients developed incident HF while 268 (47.9%) met criteria for HF suspicion. In a multivariable model, increasing age (odds ratio [OR] 1.05, 95% confidence interval [CI] 1.02\u20131.08, p\u2009&amp;lt;\u20090.001) and female sex (OR 1.85, 95% CI 1.12\u20133.04, p\u2009=\u20090.02) were associated with incident HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found a high incidence of HF in patients with biopsy-proven MASLD. Despite nearly half of patients having suspected HF, very few carried a chart diagnosis. Screening for HF in high-risk patients and establishment of formal care pathways to address early HF may reduce morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.3697","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:05:18Z","timestamp":1747717518000},"page":"2041-2048","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Incident Heart Failure is Common and Underrecognized in Patients with Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1024-9040","authenticated-orcid":false,"given":"Kara","family":"Wegermann","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Chouairi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia Sofia","family":"Karachaliou","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Ahlers","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Au","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaela","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte , Copenhagen ,","place":["Denmark"]},{"name":"Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen ,","place":["Denmark"]},{"name":"Steno Diabetes Center Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal F.","family":"Abdelmalek","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mae","family":"Diehl","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Moylan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]},{"name":"Department of Medicine, Durham Veterans Affairs Medical Center , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Duke University Health System , Durham, NC ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"2026051820015332400_ejhf3697-bib-0001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"2026051820015332400_ejhf3697-bib-0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026051820015332400_ejhf3697-bib-0003","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"2026051820015332400_ejhf3697-bib-0004","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"2026051820015332400_ejhf3697-bib-0005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gutjnl-2022-327672","article-title":"Non-alcoholic fatty liver disease and risk of new-onset heart failure: An updated meta-analysis of about 11 million individuals","volume":"72","author":"Mantovani","year":"2023","journal-title":"Gut"},{"key":"2026051820015332400_ejhf3697-bib-0006","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: A nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026051820015332400_ejhf3697-bib-0007","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: Results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"2026051820015332400_ejhf3697-bib-0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2018.07.147","article-title":"Prevalence of and characteristics associated with non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction","volume":"24","author":"Konerman","year":"2018","journal-title":"J Card Fail"},{"key":"2026051820015332400_ejhf3697-bib-0009","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026051820015332400_ejhf3697-bib-0010","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.dld.2018.09.004","article-title":"Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"50","author":"Wijarnpreecha","year":"2018","journal-title":"Dig Liver Dis"},{"key":"2026051820015332400_ejhf3697-bib-0011","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"key":"2026051820015332400_ejhf3697-bib-0012","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26610","article-title":"Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease","volume":"59","author":"Pacifico","year":"2014","journal-title":"Hepatology"},{"key":"2026051820015332400_ejhf3697-bib-0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021654","article-title":"Nonalcoholic fatty liver disease and risk of heart failure among Medicare beneficiaries","volume":"10","author":"Fudim","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026051820015332400_ejhf3697-bib-0014","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"2026051820015332400_ejhf3697-bib-0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029873","article-title":"Serum metabolites are associated with HFpEF in biopsy-proven nonalcoholic fatty liver disease","volume":"12","author":"Wegermann","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026051820015332400_ejhf3697-bib-0016","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"2026051820015332400_ejhf3697-bib-0017","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026051820015332400_ejhf3697-bib-0018","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026051820015332400_ejhf3697-bib-0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(01)05620-3","article-title":"Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study","volume":"358","author":"Davies","year":"2001","journal-title":"Lancet"},{"key":"2026051820015332400_ejhf3697-bib-0020","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/bmj.316.7141.1369","article-title":"North of England evidence based development project: Guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure","volume":"316","author":"Eccles","year":"1998","journal-title":"BMJ"},{"key":"2026051820015332400_ejhf3697-bib-0021","first-page":"615","article-title":"The barriers to effective management of heart failure in general practice","volume":"51","author":"Hickling","year":"2001","journal-title":"Br J Gen Pract"},{"key":"2026051820015332400_ejhf3697-bib-0022","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2022.01.007","article-title":"Female sex-specific and -predominant cardiovascular risk factors and heart failure practice guidelines","volume":"247","author":"Hassan","year":"2022","journal-title":"Am Heart J"},{"key":"2026051820015332400_ejhf3697-bib-0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010841","article-title":"Sex and age differences in the association between metabolic dysfunction-associated fatty liver disease and heart failure: A prospective cohort study","volume":"17","author":"Wu","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026051820015332400_ejhf3697-bib-0024","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"2026051820015332400_ejhf3697-bib-0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026051820015332400_ejhf3697-bib-0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101333","article-title":"Non-alcoholic fatty liver disease, heart failure, and long-term mortality: Insights from the National Health and Nutrition Examination Survey","volume":"47","author":"Minhas","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"2026051820015332400_ejhf3697-bib-0027","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.32655","article-title":"Association between the severity of nocturnal hypoxia in obstructive sleep apnea and non-alcoholic fatty liver damage","volume":"15","author":"Cakmak","year":"2015","journal-title":"Hepat Mon"},{"key":"2026051820015332400_ejhf3697-bib-0028","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive sleep apnea and cardiovascular disease: A scientific statement from the American Heart Association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"key":"2026051820015332400_ejhf3697-bib-0029","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1136\/gutjnl-2024-333074","article-title":"Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease","volume":"73","author":"Zhou","year":"2024","journal-title":"Gut"},{"key":"2026051820015332400_ejhf3697-bib-0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11892-021-01383-7","article-title":"The relationship between type 2 diabetes, NAFLD, and cardiovascular risk","volume":"21","author":"Caussy","year":"2021","journal-title":"Curr Diab Rep"},{"key":"2026051820015332400_ejhf3697-bib-0031","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: A multicenter study","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"2026051820015332400_ejhf3697-bib-0032","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/ehf2.14336","article-title":"Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction","volume":"10","author":"Cao","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026051820015332400_ejhf3697-bib-0033","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/ehf2.14087","article-title":"Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction","volume":"9","author":"Liu","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026051820015332400_ejhf3697-bib-0034","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jacbts.2021.07.010","article-title":"Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction","volume":"6","author":"Salah","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"2026051820015332400_ejhf3697-bib-0035","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.cgh.2024.03.045","article-title":"Liver fibrosis assessed via noninvasive tests is associated with incident heart failure in a general population cohort","volume":"22","author":"Hydes","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026051820015332400_ejhf3697-bib-0036","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2026051820015332400_ejhf3697-bib-0037","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ehf2.13250","article-title":"Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: Findings from TOPCAT","volume":"8","author":"Peters","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026051820015332400_ejhf3697-bib-0038","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032997","article-title":"High-sensitivity C-reactive protein is associated with heart failure hospitalization in patients with metabolic dysfunction-associated fatty liver disease and normal left ventricular ejection fraction undergoing coronary angiography","volume":"13","author":"Zhou","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026051820015332400_ejhf3697-bib-0039","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s43587-024-00652-w","article-title":"Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress","volume":"4","author":"Du","year":"2024","journal-title":"Nat Aging"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/11\/2041\/66833514\/eurjhf_27_11_2041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/11\/2041\/66833514\/eurjhf_27_11_2041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:02:02Z","timestamp":1779148922000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/27\/11\/2041\/8470147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,5,19]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3697","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"2024-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}